Inhibitory Effects of Ginsenoside Ro on the Growth of B16F10 Melanoma via Its Metabolites
- PMID: 31426477
- PMCID: PMC6721120
- DOI: 10.3390/molecules24162985
Inhibitory Effects of Ginsenoside Ro on the Growth of B16F10 Melanoma via Its Metabolites
Abstract
Ginsenoside Ro (Ro), a major saponin derived and isolated from Panax ginseng C.A. Meyer, exerts multiple biological activities. However, the anti-tumour efficacy of Ro remains unclear because of its poor in vitro effects. In this study, we confirmed that Ro has no anti-tumour activity in vitro. We explored the anti-tumour activity of Ro in vivo in B16F10 tumour-bearing mice. The results revealed that Ro considerably suppressed tumour growth with no significant side effects on immune organs and body weight. Zingibroside R1, chikusetsusaponin IVa, and calenduloside E, three metabolites of Ro, were detected in the plasma of Ro-treated tumour-bearing mice and showed excellent anti-tumour effects as well as anti-angiogenic activity. The results suggest that the metabolites play important roles in the anti-tumour efficacy of Ro in vivo. Additionally, the haemolysis test demonstrated that Ro has good biocompatibility. Taken together, the findings of this study demonstrate that Ro markedly suppresses the tumour growth of B16F10-transplanted tumours in vivo, and its anti-tumour effects are based on the biological activity of its metabolites. The anti-tumour efficacy of these metabolites is due, at least in part, to its anti-angiogenic activity.
Keywords: B16F10; anti-tumour; ginsenoside Ro; metabolites.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
Identification of two UDP-glycosyltransferases involved in the main oleanane-type ginsenosides in Panax japonicus var. major.Planta. 2021 Apr 5;253(5):91. doi: 10.1007/s00425-021-03617-0. Planta. 2021. PMID: 33818668
-
Interaction of saponin of bupleuri radix with ginseng saponin: solubilization of saikosaponin-a with chikusetsusaponin V (= ginsenoside-Ro).Chem Pharm Bull (Tokyo). 1985 Jul;33(7):2849-53. doi: 10.1248/cpb.33.2849. Chem Pharm Bull (Tokyo). 1985. PMID: 4085044 No abstract available.
-
New triterpenoid saponins from fruits specimens of Panax japonicus collected in Kumamoto and Miyazaki prefectures (1).Chem Pharm Bull (Tokyo). 2012;60(3):354-62. doi: 10.1248/cpb.60.354. Chem Pharm Bull (Tokyo). 2012. PMID: 22382416
-
[Advances in the study of derivatization of ginsenosides and their anti-tumor structure-activity relationship].Yao Xue Xue Bao. 2012 Jul;47(7):836-43. Yao Xue Xue Bao. 2012. PMID: 22993845 Review. Chinese.
-
Chemistry and cancer preventing activities of ginseng saponins and some related triterpenoid compounds.J Korean Med Sci. 2001 Dec;16 Suppl(Suppl):S28-37. doi: 10.3346/jkms.2001.16.S.S28. J Korean Med Sci. 2001. PMID: 11748374 Free PMC article. Review.
Cited by
-
The promising therapeutic potentials of ginsenosides mediated through p38 MAPK signaling inhibition.Heliyon. 2021 Nov 12;7(11):e08354. doi: 10.1016/j.heliyon.2021.e08354. eCollection 2021 Nov. Heliyon. 2021. PMID: 34825082 Free PMC article. Review.
-
Ginseng glucosyl oleanolate inhibit cervical cancer cell proliferation and angiogenesis via PI3K/AKT/HIF-1α pathway.NPJ Sci Food. 2024 Dec 19;8(1):105. doi: 10.1038/s41538-024-00341-3. NPJ Sci Food. 2024. PMID: 39702347 Free PMC article.
-
Spectrum-effect relationship between UPLC fingerprints and anti-lung cancer effect of Panax ginseng.Phytochem Anal. 2021 May;32(3):339-346. doi: 10.1002/pca.2980. Epub 2020 Aug 18. Phytochem Anal. 2021. PMID: 32808367 Free PMC article.
-
Novel glycosidase from Paenibacillus lactis 154 hydrolyzing the 28-O-β-D-glucopyranosyl ester bond of oleanane-type saponins.Appl Microbiol Biotechnol. 2024 Apr 4;108(1):282. doi: 10.1007/s00253-024-13109-2. Appl Microbiol Biotechnol. 2024. PMID: 38573330 Free PMC article.
-
Recent trends in ginseng research.J Nat Med. 2024 Jun;78(3):455-466. doi: 10.1007/s11418-024-01792-4. Epub 2024 Mar 21. J Nat Med. 2024. PMID: 38512649 Review.
References
-
- Chandra R.A., Wilhite T.J., Balboni T.A., Alexander B.M., Spektor A., Ott P.A., Ng A.K., Hodi F.S., Schoenfeld J.D. A systematic evaluation of abscopal responses following radiotherapy in patients with metastatic melanoma treated with ipilimumab. Oncoimmunology. 2015;4:e1046028. doi: 10.1080/2162402X.2015.1046028. - DOI - PMC - PubMed
-
- Duh P.-D., Chen Z.-T., Lee S.-W., Lin T.-P., Wang Y.-T., Yen W.-J., Kuo L.-F., Chu H.-L. Antiproliferative activity and apoptosis induction of Eucalyptus Citriodora resin and its major bioactive compound in melanoma B16F10 cells. J. Agr. Food Chem. 2012;60:7866–7872. doi: 10.1021/jf301068z. - DOI - PubMed
-
- Vakharia P., Yousif R., Patel K., Rangel S., West D., Nardone B. Overall risk of second primary malignancies in patients with malignant melanoma: A national US population-based study. J. Am. Acad. Dermatol. 2018;79:AB212.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
